Through multi-level systematic pharmacological analysis, they found that the specific mechanism of RGLD in the treatment of liver cancer involved cell proliferation and cell response to hypoxia, etc. Moreover, it can inhibit liver cancer through the PI3K/Akt signaling pathway, MAPK signaling pathway and TNF signaling pathway. This evidence concerns the gene TNF and liver cancer.